BRPI0815604A2 - Proteínas de streptococcus imunogênicas - Google Patents

Proteínas de streptococcus imunogênicas

Info

Publication number
BRPI0815604A2
BRPI0815604A2 BRPI0815604-2A2A BRPI0815604A BRPI0815604A2 BR PI0815604 A2 BRPI0815604 A2 BR PI0815604A2 BR PI0815604 A BRPI0815604 A BR PI0815604A BR PI0815604 A2 BRPI0815604 A2 BR PI0815604A2
Authority
BR
Brazil
Prior art keywords
streptococcus proteins
immunogenic streptococcus
immunogenic
proteins
streptococcus
Prior art date
Application number
BRPI0815604-2A2A
Other languages
English (en)
Portuguese (pt)
Inventor
Hilda Elizabeth Smith
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of BRPI0815604A2 publication Critical patent/BRPI0815604A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Pregnancy & Childbirth (AREA)
BRPI0815604-2A2A 2007-08-06 2008-08-05 Proteínas de streptococcus imunogênicas BRPI0815604A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07113844A EP2023143A1 (en) 2007-08-06 2007-08-06 Immunogenic streptococcus proteins
PCT/NL2008/050537 WO2009020391A1 (en) 2007-08-06 2008-08-05 Immunogenic streptococcus proteins

Publications (1)

Publication Number Publication Date
BRPI0815604A2 true BRPI0815604A2 (pt) 2015-03-03

Family

ID=38890252

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0815604-2A2A BRPI0815604A2 (pt) 2007-08-06 2008-08-05 Proteínas de streptococcus imunogênicas

Country Status (19)

Country Link
US (1) US20100297183A1 (OSRAM)
EP (3) EP2023143A1 (OSRAM)
JP (2) JP5462164B2 (OSRAM)
KR (1) KR20100063706A (OSRAM)
CN (1) CN101821627A (OSRAM)
AR (1) AR067830A1 (OSRAM)
AU (1) AU2008284491A1 (OSRAM)
BR (1) BRPI0815604A2 (OSRAM)
CA (1) CA2695721A1 (OSRAM)
CL (1) CL2008002320A1 (OSRAM)
CO (1) CO6270172A2 (OSRAM)
DK (1) DK2183597T3 (OSRAM)
ES (1) ES2432407T3 (OSRAM)
MX (1) MX2010001482A (OSRAM)
RU (1) RU2518315C2 (OSRAM)
TW (1) TW200911999A (OSRAM)
UA (1) UA103885C2 (OSRAM)
WO (1) WO2009020391A1 (OSRAM)
ZA (1) ZA201000806B (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1098980B1 (en) 1998-07-22 2014-09-03 Stichting Dienst Landbouwkundig Onderzoek Streptococcus suis vaccines and diagnostic tests
ATE507238T1 (de) * 2001-02-02 2011-05-15 Stichting Dienst Landbouwkundi Umwelt-regulierte gene, welche an der virulenz von streptococcus suis beteiligt sind
GB0818231D0 (en) 2008-10-06 2008-11-12 Univ Nottingham Composition
WO2015042369A2 (en) * 2013-09-19 2015-03-26 Zoetis Llc Oil-based adjuvants
US20170369529A1 (en) * 2014-12-22 2017-12-28 Hoffmann-La Roche Inc. Cell penetrating peptides
CA3001433A1 (en) 2015-10-21 2017-04-27 Minervax Aps Immunogenic fusion protein
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
RU2685957C2 (ru) * 2016-12-28 2019-04-23 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Химерный рекомбинантный белок, обладающий протективными свойствами в отношении Streptococcus pyogenes
CA3196872A1 (en) * 2020-12-23 2022-06-30 Chan Zuckerberg Biohub, Inc. Bacteria-engineered to elicit antigen-specific t cells
CN112773891B (zh) * 2021-02-01 2022-03-25 北部湾大学 卵形鲳鲹源无乳链球菌dna疫苗及其制备方法和应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283507A (en) 1990-12-20 1994-02-01 General Electric Company Regenerative braking protection for an electrically-propelled traction vehicle
NL9100510A (nl) * 1991-03-21 1992-10-16 Centraal Diergeneeskundig Inst Dna-sequenties die coderen voor kenmerken van virulentie van streptococcus suis en delen daarvan, daarvan afgeleide polypeptiden en antilichamen, alsmede toepassing daarvan bij de diagnose van en de bescherming tegen infectie met s. suis bij zoogdieren, waaronder de mens.
IT1251435B (it) 1991-09-04 1995-05-09 Sclavo Spa Vettore genetico per la integrazione multipla stabile di sequenze di dna nel genoma dei lieviti kluyveromyces lactis e saccharomyces cerevisiae e plasmidi che lo contengono.
US5928900A (en) * 1993-09-01 1999-07-27 The Rockefeller University Bacterial exported proteins and acellular vaccines based thereon
EP0804582A1 (en) * 1994-05-16 1997-11-05 The Uab Research Foundation $i(STREPTOCOCCUS PNEUMONIAE) CAPSULAR POLYSACCHARIDE GENES AND FLANKING REGIONS
US5681570A (en) * 1995-01-12 1997-10-28 Connaught Laboratories Limited Immunogenic conjugate molecules
EP0750042A1 (fr) * 1995-06-20 1996-12-27 Societe Des Produits Nestle S.A. Bactéries lactiques produisant des exopolysaccharides
AU738649B2 (en) 1996-04-26 2001-09-20 Rijksuniversiteit Te Leiden Methods for selecting and producing T cell peptide epitopes and vaccines incorporating said selected epitopes
US6800744B1 (en) * 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
EP1098980B1 (en) * 1998-07-22 2014-09-03 Stichting Dienst Landbouwkundig Onderzoek Streptococcus suis vaccines and diagnostic tests
US6582706B1 (en) * 1998-12-21 2003-06-24 Medimmune, Inc. Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural MOTIFS
WO2000077178A1 (en) * 1999-06-16 2000-12-21 Boston Biomedical Research Institute IMMUNOLOGICAL CONTROL OF β-AMYLOID LEVELS IN VIVO
DE60136356D1 (de) * 2000-06-12 2008-12-11 Univ Saskatchewan Chimäres GapC Protein aus Streptococcus und dessen Verwendung zur Impfung und Diagnostik
EP1205552A1 (en) * 2000-11-09 2002-05-15 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. Virulence of streptococci, involving ORFs from Streptococcus suis
ATE507238T1 (de) * 2001-02-02 2011-05-15 Stichting Dienst Landbouwkundi Umwelt-regulierte gene, welche an der virulenz von streptococcus suis beteiligt sind
BR0316635A (pt) * 2002-11-26 2005-10-11 Univ Tennessee Res Foundation Molécula de aderência de streptococcus uberis
EP1590368B1 (en) * 2003-01-27 2014-02-26 Københavns Universitet Compounds useful in the diagnosis and treatment of pregnancy-associated malaria
US20080175856A1 (en) * 2003-05-30 2008-07-24 Intercell Ag Enterococcus Antigens
WO2006048763A1 (en) * 2004-11-05 2006-05-11 Pharmacia & Upjohn Company Llc Anti-bacterial vaccine compositions
SI2029173T1 (sl) * 2006-06-26 2016-12-30 Macrogenics, Inc. Protitelesa, specifična za Fc RIIB, in postopki za njihovo uporabo

Also Published As

Publication number Publication date
UA103885C2 (en) 2013-12-10
RU2518315C2 (ru) 2014-06-10
EP2023143A1 (en) 2009-02-11
MX2010001482A (es) 2010-03-01
EP2660604A2 (en) 2013-11-06
CN101821627A (zh) 2010-09-01
JP2010535500A (ja) 2010-11-25
CA2695721A1 (en) 2009-02-12
AR067830A1 (es) 2009-10-21
KR20100063706A (ko) 2010-06-11
US20100297183A1 (en) 2010-11-25
DK2183597T3 (da) 2013-10-14
JP5462164B2 (ja) 2014-04-02
EP2183597A1 (en) 2010-05-12
TW200911999A (en) 2009-03-16
ZA201000806B (en) 2010-10-27
CO6270172A2 (es) 2011-04-20
EP2183597B1 (en) 2013-07-24
ES2432407T3 (es) 2013-12-03
RU2010107878A (ru) 2011-09-20
JP2014095721A (ja) 2014-05-22
WO2009020391A1 (en) 2009-02-12
CL2008002320A1 (es) 2009-09-25
AU2008284491A1 (en) 2009-02-12
EP2660604A3 (en) 2014-02-12

Similar Documents

Publication Publication Date Title
DK3118221T3 (da) Proteiner
BRPI0814252A2 (pt) Formulações de anticorpo
PT2889310T (pt) Formulações de anticorpo
BRPI0820114A2 (pt) Engenharia de proteínas enzimaticamente suscetíveis
SI2126093T1 (sl) Izboljšanje priprave proteinov
ATE450271T1 (de) Impfstoff
EP2215246A4 (en) PROTEIN SCAFFOLDS
BRPI0820819A2 (pt) Formulação de anticorpos
BRPI0807453A2 (pt) Preparação sólida
DK2046826T3 (da) Exendin-fusionsproteiner
DK2114993T3 (da) Vaccine
HUE045482T2 (hu) Immunogén készítmény
DK2307543T3 (da) Forbedret proteinekspressionssystem
HRP20170963T1 (hr) Modificirani saharidi
FR2913672B1 (fr) Joint thermoscellable
PT2180901E (pt) Purificação de conjugados utilizando hidroxiapatite
DK2132326T3 (da) Fremgangsmåder
BRPI0814971A2 (pt) Proteína
BRPI0815604A2 (pt) Proteínas de streptococcus imunogênicas
BRPI0814188A2 (pt) Formulações
DK2125048T3 (da) Præparat
BRPI0811551A2 (pt) Articulação de quatro pontos
BRPI0815203A2 (pt) gel contendo pirfenidona
BRPI0819344A2 (pt) motor
BRPI0809678A2 (pt) Métodos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.